REV CARDIOVASC MED 润色咨询

Reviews in Cardiovascular Medicine

出版年份：2000 年文章数：435 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：0.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2022-07-12 ms2000000130062631

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：心血管临床研究
    经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。

    28

    展开28条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2022-04-13 ms6000000288353789

    请问Pending APC Confirm是什么状态？

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2023-02-01 ms4000000551243997 来自江西省

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2022-08-03 ms6000000673439938

    投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2022-11-13 ms5000001082491503

    pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2023-11-30 是金子总会发光 来自上海

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：心内
    经验分享：请问接受后多久能出版文章呀？PDF版本快吗？

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2023-03-04 ms4000001177268613 来自河南省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：心血管临床
    经验分享：2022.10.20投稿 第二天送审
    2023.2.14大修 两位审稿人提了比较好的意见
    2023.2.21重新提交修改稿
    2023.2.28小修 小问题当天就返修
    2023.3.1接收
    编辑处理稿件的效率很高，回复问题也及时。

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2019-05-13 aliceyang2018_63388764

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了

    另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml
    投稿链接是：https://www.editorialmanager.com/rcm/default.aspx

    请叫我雷锋，嘿嘿

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2021-08-15 ms2000001529972856

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1231993, encodeId=62581231993f2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：心血管临床研究<br>经验分享：投过两篇RCM，一篇拒稿，一篇接受。感觉这个文章对于文章创新性要求不高，对于入选患者的数量有较高要求。拒稿那篇300多个患者，一个功能学加临床随访，没有外审就拒掉了。另外一个800多名患者，审稿3周后，小修，7天后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e35408773, createdName=ms2000000130062631, createdTime=Tue Jul 12 13:54:29 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210930, encodeId=72fa1210930fd, content=请问Pending APC Confirm是什么状态？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ac5598839, createdName=ms6000000288353789, createdTime=Wed Apr 13 19:41:27 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112530, encodeId=451c211253046, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：我的文章接收3个月了，还是在WOS上检索不到，就怕它被剔除SCI了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade25636225, createdName=ms4000000551243997, createdTime=Wed Feb 01 09:50:52 CST 2023, time=2023-02-01, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1236460, encodeId=07041236460db, content=投稿一周了，一直是pending pre check，这是什么状态？还在编辑手里嘛？找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Wed Aug 03 21:42:14 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100287, encodeId=db92210028e35, content=pubmed检索这个杂志，更新速度很慢，现在最近的是22年3月份发表的文章，这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f208127400, createdName=ms5000001082491503, createdTime=Sun Nov 13 17:34:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172226, encodeId=aa4621e2226dd, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：心内<br>经验分享：请问接受后多久能出版文章呀？PDF版本快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=是金子总会发光, createdTime=Thu Nov 30 22:43:30 CST 2023, time=2023-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117448, encodeId=e8bb211e4488c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管临床<br>经验分享：2022.10.20投稿 第二天送审<br>2023.2.14大修 两位审稿人提了比较好的意见<br>2023.2.21重新提交修改稿<br>2023.2.28小修 小问题当天就返修<br>2023.3.1接收<br>编辑处理稿件的效率很高，回复问题也及时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/62813cef6f254525b287e64787604342/a68ad9d557d84f2194d1cc4f6209643e.jpg, createdBy=a3505584795, createdName=ms4000001177268613, createdTime=Sat Mar 04 10:22:33 CST 2023, time=2023-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=570859, encodeId=b8555e085991, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：这个刊物效率很好，基本审稿1个月内，出版3个月内，适合应急。我投的第一篇10天就录用了，3个审稿人,关键反馈效率特别高，每次发邮件都是当天回复我信息，比其他一些杳无音信的期刊强万倍了 <br> <br> 另外这个期刊的准确的官网是：https://rcm.imrpress.org/EN/2153-8174/home.shtml <br> 投稿链接是：https://www.editorialmanager.com/rcm/default.aspx <br> <br> 请叫我雷锋，嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6dc2488490, createdName=aliceyang2018_63388764, createdTime=Mon May 13 16:18:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008082, encodeId=94c410080829c, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：3天with editor 9天under review，外审两周后给出大修，修改完后一周小修，然后一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Sun Aug 15 15:32:09 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852711, encodeId=95ab852e11cd, content=投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会； , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jul 19 18:17:10 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2019-07-19 ms1875852553058278

    投了5天就收到了杂志社的反馈邮件，帮我送审了2位审稿人，专业外审通过之后，在语言审核环节，杂志社的耐心很好，给了我多次修改润色的机会；

    3

    展开3条回复
共125条页码: 1/13页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分